title: Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
authors.affiliation: National University Hospital Rigshospitalet and State Serum Institute, Copenhagen, Denmark. terese@rh.dk
authors.forename: T L
authors.initials: TL
authors.lastname: Katzenstein
authors.forename: E
authors.initials: E
authors.lastname: Dickmeiss
authors.forename: H
authors.initials: H
authors.lastname: Aladdin
authors.forename: A
authors.initials: A
authors.lastname: Hede
authors.forename: C
authors.initials: C
authors.lastname: Nielsen
authors.forename: H
authors.initials: H
authors.lastname: Nielsen
authors.forename: L B
authors.initials: LB
authors.lastname: Jørgensen
authors.forename: J
authors.initials: J
authors.lastname: Gerstoft
mesh_terms: D000293:Adolescent; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission* / Q000821:virology; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D019888:Nelfinavir / Q000627:therapeutic use; D065227:Transfusion Reaction; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D019888:Nelfinavir